Adani Energy Solutions Fund Raise of ₹8,373 Cr

Adani Energy Solutions Earnings Call Transcript: Key Takeaways

Adani Energy delivered robust growth driven by transmission commissioning and a mature energy solutions platform.

Adani Energy Solutions Investor Presentation: Key Takeaways

Adani Energy Solutions reported record performance for Q2 FY27, driven by strong growth in transmission and the inclusion of the energy solutions platform. The company is scaling smart metering and transmission networks.

Adani Energy Solutions Management Change

Adani Energy Solutions appointed Mr. Arvind Sharma as CISO and Mr. Rahul Bhutiani as Chief – Strategic Customer Acquisition, effective October 22, 2026.

Adani Energy Solutions Results Update

AESL reported Q2FY27 PAT of Rs 1,364 crore and EBITDA of Rs 3,548 crore, both record highs. A 2,500 MW MSEDCL RTC power contract is also highlighted.

RTC power supply capacity (PPA with MSEDCL)

2500 MW

Order book

₹87,000 Cr

Adani Energy Solutions Q2 FY27 Results: Net Profit ₹1,364 Cr, Up 144.8% YoY

Adani Energy Solutions Ltd reported revenue from operations of ₹10,076 Cr (+52.8% YoY) and net profit of ₹1,364 Cr (+144.8% YoY) for Q2 FY27.

Key figure

Net profit ₹1,364 Cr · +144.8% YoY

Adani Energy Solutions Other Announcement

Adani Energy Solutions Limited submitted the certificate from its Registrar and Share Transfer Agent, MUFG Intime India Private Limited, under Regulation 74(5) for the September 2026 quarter.

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.

Gujarat Inject (Kerala) Fund Raise of ₹3 Cr

Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.

Value

₹3.00 Cr